@inproceedings{inproceedings, title  = {{Laboratory safety of dupilumab in paediatric patients aged >= 6 to < 12 years with severe atopic dermatitis: results from a phase III trial (LIBERTY AD PEDS)}},

 url = {{}},

 year = {{2021}},

 month = {{1}},

 author = {{Wollenberg A and Thaci D and Cork MJ and Arkwright PD and Gooderham M and Sun X and Vakil J and Khokhar FA}},

 volume = {{185}},

 journal = {{BRITISH JOURNAL OF DERMATOLOGY}},

 issue = {{3}},

 pages = {{E122-E123}},

 note = {{Accessed on 2024/12/22}}}